Connection

MUSAFFE TUNA to Female

This is a "connection" page, showing publications MUSAFFE TUNA has written about Female.
Connection Strength

0.154
  1. Clinical relevance of TP53 hotspot mutations in high-grade serous ovarian cancers. Br J Cancer. 2020 02; 122(3):405-412.
    View in: PubMed
    Score: 0.027
  2. Genome-Wide Profiling of Acquired Uniparental Disomy Reveals Prognostic Factors in Head and Neck Squamous Cell Carcinoma. Neoplasia. 2019 11; 21(11):1102-1109.
    View in: PubMed
    Score: 0.027
  3. Next generation sequencing and its applications in HPV-associated cancers. Oncotarget. 2017 Jan 31; 8(5):8877-8889.
    View in: PubMed
    Score: 0.022
  4. Prognostic relevance of acquired uniparental disomy in serous ovarian cancer. Mol Cancer. 2015 Feb 03; 14:29.
    View in: PubMed
    Score: 0.019
  5. Insulin-like growth factor I regulates the expression of isoforms of Wilms' tumor 1 gene in breast cancer. Tumori. 2013 Nov-Dec; 99(6):715-22.
    View in: PubMed
    Score: 0.018
  6. Prognostic value of acquired uniparental disomy (aUPD) in primary breast cancer. Breast Cancer Res Treat. 2012 Feb; 132(1):189-96.
    View in: PubMed
    Score: 0.015
  7. Association between acquired uniparental disomy and homozygous mutations and HER2/ER/PR status in breast cancer. PLoS One. 2010 Nov 30; 5(11):e15094.
    View in: PubMed
    Score: 0.014
  8. HER2/neu increases the expression of Wilms' Tumor 1 (WT1) protein to stimulate S-phase proliferation and inhibit apoptosis in breast cancer cells. Oncogene. 2005 Feb 24; 24(9):1648-52.
    View in: PubMed
    Score: 0.010
  9. Cyclooxygenase-2 is essential for HER2/neu to suppress N- (4-hydroxyphenyl)retinamide apoptotic effects in breast cancer cells. Cancer Res. 2004 Feb 15; 64(4):1224-8.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.